Skip to content

Clinical trials

Observational Inflammation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Observational Country / region: China Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20134
20143
20161
20191
20208
20212
20225
20237
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16
Completed12
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital4
Beijing Anzhen Hospital2
Central South University2
Guangzhou Institute of Respiratory Disease2
Huashan Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Shandong University2
Anhui Medical University1
Beijing Tongren Hospital1
Chang-Ming Huang, Prof.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation39
Coronary Artery Disease5
Coronary Restenosis3
Coronary Stenosis3
Disease Progression3
Sepsis3
Stomach Neoplasms3
Cognitive Dysfunction2
Fibrosis2
Respiratory Distress Syndrome2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.